Sphingomyelin in Lewy inclusion bodies in Parkinson's disease. 1969

W A den Jager

UI MeSH Term Description Entries
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D010301 Parkinson Disease, Postencephalitic Parkinsonism following encephalitis, historically seen as a sequella of encephalitis lethargica (Von Economo Encephalitis). The early age of onset, the rapid progression of symptoms followed by stabilization, and the presence of a variety of other neurological disorders (e.g., sociopathic behavior; TICS; MUSCLE SPASMS; oculogyric crises; hyperphagia; and bizarre movements) distinguish this condition from primary PARKINSON DISEASE. Pathologic features include neuronal loss and gliosis concentrated in the MESENCEPHALON; SUBTHALAMUS; and HYPOTHALAMUS. (From Adams et al., Principles of Neurology, 6th ed, p754) Encephalitis Lethargica Type Parkinsonism,Parkinsonism, Viral Meningoencephalitic,Postencephalitic Parkinsonism,Parkinson Disease, Post-Encephalitic,Parkinsonian Syndrome, Postencephalitis,Parkinsonism, Postencephalitic,Post-Encephalitic Parkinson Disease,Postencephalitic Economo-Type Parkinsonism,Postencephalitic Parkinson Disease,Viral Meningoencephalitic Parkinsonism,von Economo Encephalitis Type Parkinsonism,Economo-Type Parkinsonism, Postencephalitic,Meningoencephalitic Parkinsonism, Viral,Parkinson Disease, Post Encephalitic,Parkinsonism, Postencephalitic Economo-Type,Parkinsonisms, Viral Meningoencephalitic,Post Encephalitic Parkinson Disease,Postencephalitic Economo Type Parkinsonism,Postencephalitis Parkinsonian Syndrome
D003594 Cytoplasmic Granules Condensed areas of cellular material that may be bounded by a membrane. Cytoplasmic Granule,Granule, Cytoplasmic,Granules, Cytoplasmic
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D006651 Histocytochemistry Study of intracellular distribution of chemicals, reaction sites, enzymes, etc., by means of staining reactions, radioactive isotope uptake, selective metal distribution in electron microscopy, or other methods. Cytochemistry
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013109 Sphingomyelins A class of sphingolipids found largely in the brain and other nervous tissue. They contain phosphocholine or phosphoethanolamine as their polar head group so therefore are the only sphingolipids classified as PHOSPHOLIPIDS. Sphingomyelin
D013194 Staining and Labeling The marking of biological material with a dye or other reagent for the purpose of identifying and quantitating components of tissues, cells or their extracts. Histological Labeling,Staining,Histological Labelings,Labeling and Staining,Labeling, Histological,Labelings, Histological,Stainings

Related Publications

W A den Jager
January 1992, Acta neuropathologica,
W A den Jager
June 1999, Elderly care,
W A den Jager
May 2004, Parkinsonism & related disorders,
W A den Jager
September 2005, Experimental neurology,
W A den Jager
January 2003, Bulletin de l'Academie nationale de medecine,
W A den Jager
September 1983, Science (New York, N.Y.),
W A den Jager
November 2006, Molecular neurodegeneration,
W A den Jager
August 2000, Acta neuropathologica,
Copied contents to your clipboard!